Your session is about to expire
← Back to Search
Statins for Breast Cancer
Study Summary
This trial is testing whether the cholesterol-lowering medication atorvastatin can reduce the risk of breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 58 Patients • NCT02084069Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not in another breast cancer prevention trial.I am taking medication that could interact with statins.I am at high risk for breast cancer based on specific criteria.My family has a strong history of breast or ovarian cancer.My liver function tests are higher than normal.I am on hormone replacement therapy, but only use topical estrogen.I am allergic to atorvastatin or its ingredients.I or a family member have a BRCA1/2 gene mutation.My breast cancer risk over the next 5 years is higher than 1.67%.I am 35 years old or older.I had breast cancer (stage 0-IIIb) and finished all treatments over a year ago.My biopsy showed abnormal cell growth or LCIS.I am a pre-menopausal woman with regular periods over the last 6 months.I am a woman who can and will sign a consent form.I am a woman currently on statins or haven't taken any in the last 6 months.I am currently taking tamoxifen, raloxifene, or an aromatase inhibitor.I have had stage IV breast or ovarian cancer in the past.
- Group 1: Sugar Pill
- Group 2: Atorvastatin
- Approved for 30 Other Conditions - This treatment demonstrated efficacy for 30 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Which patient population is this clinical trial meant for?
"This clinical trial is only admitting women aged 35-55 that have breast cancer. They are looking for around 100 participants in total."
What is the primary use that Atorvastatin has been FDA approved for?
"Atorvastatin is most often used to manage lipidemias, but it can also help patients who have postoperative thromboembolism, anginal pain, and transient ischemic attack."
Has the Food and Drug Administration accepted Atorvastatin?
"Since this is a Phase 2 trial, there is only data supporting safety, not efficacy. As such, our team has given Atorvastatin a score of 2."
Are there any patients presently enrolled in this clinical trial?
"According to the latest information from clinicaltrials.gov, this particular trial is not looking for patients at this time. This study was originally posted on January 1st, 2005 but hasn't been updated since February 10th, 2010. Although this research isn't currently recruiting people, there are 2,771 other trials that are actively searching for participants right now."
Are there different hospitals or research centers participating in this trial across the state?
"There are 7 study sites for this research project, which are located in cities such as San Francisco, Las Vegas and Newark. If you want to enroll, it would be advantageous to choose the location nearest you to limit travel."
How many test subjects are in this experiment?
"This particular study is no longer recruiting patients for participation. The trial was initially posted on 1/1/2005 and was most recently edited on 2/10/2010. However, there are presently 2698 clinical trials actively admitting patients with breast cancer and 73 trials for Atorvastatin that are still looking for participants."
Is this research project only enrolling seniors?
"The aim of this study is to enroll patients that are 35-55 years old."
What is Atorvastatin's clinical trial history?
"The first clinical trial for atorvastatin was completed in 2005 and hosted by OHSU Hospital. Since then, a total of 18669 clinical trials have been completed globally. There are 73 active studies recruiting patients as of now, with many taking place in San Francisco, California."
What makes this experiment unique compared to others like it?
"Atorvastatin has been researched since 2005, when the first study was completed and sponsored by Merck Sharp & Dohme LLC. The initial trial involved 80 participants. Since then, there have been 73 live trials for Atorvastatin across 162 cities and 28 countries."
Share this study with friends
Copy Link
Messenger